The world’s only continually updated database of CAR-T cell therapy companies that is publicly available.
Limited-Time Offer for 50% Off | Featuring 191 Companies Worldwide
CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the power to recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.”
Since the first historic CAR-T approvals in 2017, the following products have been approved by the U.S. FDA:
- Kymriah (tisagenlecleucel)
- Yescarta (axicabtagene ciloleucel)
- Tecartus (brexucabtagene autoleucel)
- Breyanzi (lisocabtagene maraleucel)
- Abecma (idecabtagene vicleucel)
- Carvykti (Ciltacabtagene autoleucel)
CAR-T therapies have reached commercialization in other regions as well, such as Relma-cel’s (Relmacabtagene) approval from the NMPA in China and Ebvallo’s (tabelecleucel) approval from the European Commission.
These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding market, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 191 worldwide.
We originally developed this database for our own purposes, but more and more of our readers have requested access to it.
CAR-T Company Database
This database features the following information for all known CAR-T market competitors:
Description of CAR-T Involvement
City / State
Link to CAR-T Programs
Use this searchable database of CAR-T companies to:
- Identify global competitors within the CAR-T marketplace
- Quantify CAR-T products in late-stage development
- Reveal preclinical and clinical programs supporting CAR-T development
- Spot regions that are “hotspots” for CAR-T companies
- Identify potential partners and collaborators
It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.
Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident that you will find it to be invaluable resource.
When you check out below, your product will be delivered instantly as an Excel download. Of course, your investment is backed by a Greater than 100% Money Back Guarantee.